Impact of obesity on IgA nephropathy: Comparative ultrastructural study between obese and non-obese patients

Nephron - Clinical Practice

Volumn 112, Issue 2, 2009, Pages

  Tanaka, Mari ^a   Yamada, Sachiko ^a   Iwasaki, Yukako ^a   Sugishita, Takeshi ^a   Yonemoto, Satomi ^a   Tsukamoto, Tatsuo ^a   Fukui, Satoshi ^a   Takasu, Kosho ^a   Muso, Eri ^a  

^a Kitano Hospital   (Japan)

Author keywords

Body mass index; Glomerular basement membrane; Glomerular hypertrophy; IgA nephropathy; Obesity; Overweight; Proteinuria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MESANGIUM; OBESITY; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BIOPSY; BODY MASS INDEX; COMORBIDITY; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; INCIDENCE; JAPAN; KIDNEY; OBESITY; RISK ASSESSMENT; RISK FACTORS;

EID: 65449155572     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213084     Document Type: Article

References (19)

1. Skidmore PM, Yarnell JW: The obesity epidemic: prospects for prevention. QJM 2004; 97:817-825.
2. Verani RR: Obesity-associated focal seg-mental glomerulosclerosis: pathological features of the lesion and relationship with car-diomegaly and hyperlipidemia. Am J Kidney Dis 1992;20:629-634.
3. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopa-thy: an emerging epidemic. Kidney Int 2001; 59:1498-1509.
4. Praga M, Hernandez E, Morales E, Campos AP, Valero MA, Martinez MA, Leon M: Clinical features and long-term outcome of obesity-associated focal segmental glomeru-losclerosis. Nephrol Dial Transplant 2001; 16:1790-1798.
5. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001;37:720-727.
6. D'Amico G: The commonest glomerulone-phritis in the world: IgA nephropathy. QJM 1987;64:709-727.
7. Navas-Pa lacios JJ, Gutierrez-Mi llet V, Usera-Sarrage G, Garzon-Martin A: IgA nephropa-thy: an ultrastructural study. Ultrastruct Pathol 1981;2:151-161.
8. Taguchi T, von Bassewitz DB, Grundmann E, Takebayashi S: Ultrastructural changes of glomerular basement membrane in IgA nephritis: relationship to hematuria. Ultra-struct Pathol 1988;12:17-26.
9. Obesity: Preventing and Managing t he Global Epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894: 1-253.
10. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998;6:51S-209S .
11. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002;66:987-992.
12. Caramori ML, Basgen JM, Mauer M: Glo-merular structure in the normal human kidney: differences between living and cadaver donors. J Am Soc Nephrol 2003;14:1901-1903.
13. Rea DJ, Heimbach JK, Grande JP, Textor SC, Taler SJ, Prieto M, Larson TS, Cosio FG, Stegall MD: Glomerular volume and renal histology in obese and non-obese living kidney donors. K idney Int 2006;70:1636-1641.
14. Serra A, Romero R, Lopez D, Navarro M, Es-teve A, Perez N, Alastrue A, Ariza A: Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008;73: 947-955.
15. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanom-sup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366: 1640-1649.
16. White KE, Bilous RW: Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000;11: 1667-1673.
17. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-1217.
18. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867.
19. Coppo R, Peruzzi L, Amore A, Piccoli A, Co-chat P, Stone R, Kirschstein M, Linne T: IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 2007;18:1880-1888.